×

img Accessibility Controls

Technologies Banner

All Technologies

Recombinant Streptokinase (rSK)-CSIR's Second- Generation Clot Buster

Project Overview

Developed a facile process to manufacture a recombinant version of natural type streptokinase which is roughly ten times efficient as the natural SK production technology.

Benefits

1. Cost effective.
2. More efficent than natural streptokinase

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Manufacturing of Streptokinase
Source Title
Output
TRL: Technology Readiness Level
Market Launch
arrowtop
Latest Updates
Loading…